OXY00401
LifeTECH Corporation 1995 Annual Report Information

OXY00402
LifeTECH Confirms Viral Inactivation in Intravenous Immunoglobulin by Sterizone(TM) System

OXY00403
LifeTECH Scientists to Present Abstract at the Annual Meeting of The American Association of Blood Banks

OXY00404
LifeTECH Scientists to Present Human IGG Abstract to Biennial Meeting of The International Society for Free Radical Research

OXY00405
LifeTECH Scientists to Present Second Abstract at the Annual Meeting of The American Association of Blood Banks

OXY00406
LifeTECH Corporation Reports Results for the Third Quarter and Nine Months Ended July 31, 1996.

OXY00407
Dr. Mel Krajden Appointed to LifeTECH's Scientific Advisory Board

OXY00408
LifeTECH Research Supported by $100,000 NRC/IRAP Grant; Third Party Validation of Sterinetics Technology

OXY00409
LifeTECH Scientists to Present Four Abstracts on Blood Sterilization to The 3rd Annual Meeting of The Oxygen Society

OXY00410
LifeTECH Announces Technology Name Change

OXY00411
LifeTECH's Sterinetics(TM) System Achieves Multiple Viral Inactivation in Intravenous Immunoglobulin

OXY00412
Independent Research Confirms Inactivation of Simian Immunodeficiency Virus by LifeTECH's Sterinetics(TM) System

OXY00413
Mechanisms of cerebral vasodilation by superoxide hydrogen peroxide and peroxynitrite.

OXY00414
LifeTech Announces Strategic Alliance with Pall Corporation

OXY00415
LifeTECH Corporation Reports Results for the Fiscal Year Ended October 31, 1996 and for the Three Months Ended January 31, 1997 - March 20 1997

OXY00416
LifeTECH Introduces New Internet Web Site - March 26 1997

OXY00417
Dr. James Lepock and Dr. Martin Petric Appointed to LifeTECH's Scientific Advisory Board - April 2 1997

OXY00418
LifeTECH Abstract on Viral Inactivation in Human Red Blood Cells to be Presented at Experimental Biology '97 Conference - April 8 1997

OXY00419
LifeTECH Invited to Address Third Annual Blood Safety & Screening Conference - April 16 1997

OXY00420
Oxidants and antioxidants. Biological effects and therapeutic perspectives. (Abstract)

OXY00421
Effect of stereochemistry on the oxidative metabolism of the cyclophosphamide metabolite aldophosphamide. (Abstract)

OXY00422
Efficacy of ozonated water against various food-related microorganisms. (Abstract)

OXY00423
Bactericidal effects of ozone at nonspermicidal concentrations. (Abstract)

OXY00424
Influence of ozone on haemoglobin oxygen affinity in type-2 diabetic patients with peripheral vascular disease: in vitro studies. (Abstract)

OXY00425
Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. (Abstract)

OXY00426
Prolonged contrast infusion echocardiography with hydrogen peroxide. (Abstract)

OXY00427
Hydrogen peroxide: a review of its use in dentistry. (Abstract)

OXY00428
Bacteria in human mouths involved in the production and utilization of hydrogen peroxide. (Abstract)

OXY00429
Oxidants and antioxidants. Biological effects and therapeutic perspectives (Abstract)

OXY00430
Medical Lobby Maintains Choke Hold To Restrict Access to Health Alternatives - by Byrun Fox - Media Bypass Magazine October 1996

OXY00431
Warburg, Blass and Koch: Men With A Message. - By G.A. Freibott - International Association for Oxygen Therapy

OXY00432
The International Association for Oxygen Therapy - Information Bulletin Number One - Ozone: Its Therapeutic Action

OXY00433
Oxidation the Key to Real Health - Lynn Terry interviews Dr. George Freibott

OXY00434
Dr. Albeizt Szent-Gyorgyi - 1937 Nobel Prize Winner - 45 Years Later. From: International Association for Oxygen

OXY00435
Medical students and alternative medicine--a survey. - Abstract

OXY00436
LifeTECH Strategic Alliance with Pall Corporation Not Completed Research & Development Cooperation to Continue with Pall Alternative Alliance Targeted Over the Coming Months - May 7 1997

OXY00437
From Keep Hope Alive's Ozone and H2O2 article: HYDROGEN PEROXIDE AND IRON (well water) -- A BAD COMBINATION H2O2 and Distilled Water - No Problems

OXY00438
The Reversal of Scleroderma Report of Two Cases - By Ronald M. Davis, M.D.

OXY00439
Treatment of Hepatitis C with Intravenous Hydrogen Peroxide Report of One Case - By Ronald M. Davis, M.D.

OXY00440
Ozone - Treatment of Blood; Treatment of HIV. A letter from Samuel W. Murdoch, Attorney at Law to Mr. Michael Thesz - Office of Assistant Commissioner for Patents dated May 19, 1992. Posted by Joseph Passeroon Wed, Nov 20, 1996 on the Oxytherapy Mailing List

OXY00441
The Seeming Anomaly of Hydrogen Peroxide - From The Townsend Letter for Doctors & Patients - June 1996

OXY00442
A Note on Mitogenetic Radiation and Oxygen - by Vladimir Voeikov

OXY00443
The Role of Electron Excited States in Biochemical Processes.

OXY00444
Initiation of Degenerate Branched Chain Reaction of Glycin Deamination with Ultraweak UV-Irradiation or Hydrogen Peroxide

OXY00445
Ozone + Total Approach - A.J. Lanigan. From the Oxytherapy Mailing List.

OXY00446
Not an Ozone Doctor - A.J. Lanigan. From the Oxytherapy Mailing List.

OXY00447
Specific Defense Mechanisms - A.J. Lanigan. From the Oxytherapy Mailing List.

OXY00448
Ozone & The Immune System - Part 1 - A.J. Lanigan. From the Oxytherapy Mailing List.

OXY00449
Ozone & The Immune System - Part 2 - A.J. Lanigan. From the Oxytherapy Mailing List.

OXY00450
Ozone & The Immune System - Part 3 - A.J. Lanigan. From the Oxytherapy Mailing List.